Heparin Protocol for Left Heart Catheterization
Initial Dosing
- The American Heart Association recommends an initial unfractionated heparin bolus of 100 U/kg (maximum 5000 U) administered intravenously at the start of the procedure to maintain ACT levels >200 seconds during left heart catheterization 1, 2
- For prolonged procedures (>60 minutes), additional boluses or a continuous infusion should be used to maintain adequate anticoagulation, as recommended by the American College of Cardiology 1
- The target ACT should be >200 seconds for standard procedures, but consider higher targets (250-300 seconds) for high-risk thrombotic procedures, according to the American Heart Association 3
Monitoring Protocol
- The American Heart Association suggests measuring ACT approximately 1 hour after the initial bolus and then every 30 minutes for longer procedures to maintain adequate anticoagulation 3
- Additional heparin (50-100 U/kg) should be administered as needed to maintain ACT >200 seconds, as recommended by the American College of Cardiology 3
Special Considerations
- Weight-based dosing is critical, as fixed-dose protocols may result in significant over or under-anticoagulation, according to the American Heart Association 3
- For patients with renal impairment, no dose adjustment is required for unfractionated heparin, as stated by the Mayo Clinic 4
- If the patient has a history of heparin-induced thrombocytopenia (HIT), alternative anticoagulation strategies, such as bivalirudin, must be used, as recommended by the Anaesthesia society 5, 6
Post-Procedure Management
- After completion of the procedure, heparin effect typically wanes without specific reversal, according to the American Heart Association 1
- If immediate reversal is needed, protamine can be administered (1 mg of protamine per 100 units of heparin given in the preceding 2-3 hours), as recommended by the Anaesthesia society 5
- Monitor for post-procedure arterial thrombosis, particularly in pediatric patients or those with small vessels, as suggested by the American Heart Association 3
Alternative Anticoagulants
- For patients with HIT, bivalirudin is the preferred alternative, with a recommended dosing of IV bolus of 0.75 mg/kg followed by infusion at 1.75 mg/kg/hour during the procedure, according to the Anaesthesia society 6
- If ACT <225 seconds after bolus, increase infusion rate by 0.25 mg/kg/hour, as recommended by the Anaesthesia society 6
- For patients with moderate renal impairment (CrCl 30-59 mL/min), start infusion at 1.4 mg/kg/hour, as suggested by the Anaesthesia society 6
Common Pitfalls
- Inadequate initial dosing leading to subtherapeutic anticoagulation and increased thrombotic risk is a common pitfall, according to the American Heart Association 1
- Failure to monitor ACT during prolonged procedures, resulting in inconsistent anticoagulation, is another common pitfall, as stated by the American College of Cardiology 3
- Overlooking the possibility of HIT in patients with previous heparin exposure is a critical pitfall, according to the Anaesthesia society 5
Management of Heparin During Heart Catheterization
General Recommendations for Heparin Administration
- For patients undergoing transseptal puncture, heparin should be given after the puncture is completed to avoid increasing bleeding risk, as recommended by the American Heart Association 7
- For left ventricular puncture procedures, heparin should be discontinued 4-6 hours before the procedure and can be restarted without a bolus more than 4 hours after peripheral vessel sheath removal, according to the American Heart Association 7
Special Considerations
Access Route Considerations
- For transradial access, standard heparin dosing (100 U/kg) is appropriate, and radial access is recommended when possible given the lower bleeding risk, as suggested by the American College of Cardiology 8
- For transfemoral access, consider using vascular closure devices to minimize bleeding risk, and higher heparin doses may be required to maintain adequate anticoagulation, as recommended by the American College of Cardiology 8, 9
High Thrombotic Risk Patients
- For patients with mechanical heart valves or recent stroke, uninterrupted anticoagulation or minimal interruption is recommended, according to the European Society of Cardiology 10
- For patients at very high thrombotic risk, bridging with heparin should be started when INR falls below 2.0, as suggested by the American Heart Association 7
Common Pitfalls to Avoid
- Crossing over between different anticoagulants (e.g., switching between unfractionated heparin and LMWH) increases bleeding risk, as reported by the European Society of Cardiology 11
Post-Procedure Management
- After uncomplicated coronary intervention, there appears to be little value in continuing heparin therapy, and routine use of unfractionated heparin after an uncomplicated coronary angioplasty is no longer recommended, as stated by the American Heart Association 12
- For patients on oral anticoagulants, restart therapy after careful evaluation of bleeding risk and post-procedure complications, as recommended by the American College of Cardiology 8, 9